Published in EMBO Mol Med on January 26, 2011
Coagulase-negative staphylococci. Clin Microbiol Rev (2014) 1.85
Alternative Evolutionary Pathways for Drug-Resistant Small Colony Variant Mutants in Staphylococcus aureus. MBio (2017) 1.40
Intracellular Staphylococcus aureus: live-in and let die. Front Cell Infect Microbiol (2012) 1.33
PSMs of hypervirulent Staphylococcus aureus act as intracellular toxins that kill infected osteoblasts. PLoS One (2013) 1.26
Staphylococcus aureus persisters tolerant to bactericidal antibiotics. J Mol Microbiol Biotechnol (2012) 1.25
Phenol-soluble modulins--critical determinants of staphylococcal virulence. FEMS Microbiol Rev (2014) 1.21
Immunization with Staphylococcus aureus iron regulated surface determinant B (IsdB) confers protection via Th17/IL17 pathway in a murine sepsis model. Hum Vaccin Immunother (2012) 1.20
Staphylococcus aureus Small Colony Variants (SCVs): a road map for the metabolic pathways involved in persistent infections. Front Cell Infect Microbiol (2014) 1.20
Staphylococcal alpha-phenol soluble modulins contribute to neutrophil lysis after phagocytosis. Cell Microbiol (2013) 1.19
Adaptive evolution of Staphylococcus aureus during chronic endobronchial infection of a cystic fibrosis patient. PLoS One (2011) 1.17
Inactivation of thyA in Staphylococcus aureus attenuates virulence and has a strong impact on metabolism and virulence gene expression. MBio (2014) 1.09
Cytoplasmic replication of Staphylococcus aureus upon phagosomal escape triggered by phenol-soluble modulin α. Cell Microbiol (2013) 1.06
Discovery of functional toxin/antitoxin systems in bacteria by shotgun cloning. Mol Cell (2013) 1.05
Pseudomonas aeruginosa Diversification during Infection Development in Cystic Fibrosis Lungs-A Review. Pathogens (2014) 1.05
Persistent bacterial infections, antibiotic tolerance, and the oxidative stress response. Virulence (2013) 1.04
Combined action of influenza virus and Staphylococcus aureus panton-valentine leukocidin provokes severe lung epithelium damage. J Infect Dis (2012) 1.03
The RpoB H₄₈₁Y rifampicin resistance mutation and an active stringent response reduce virulence and increase resistance to innate immune responses in Staphylococcus aureus. J Infect Dis (2012) 1.02
Staphylococcal Esx proteins modulate apoptosis and release of intracellular Staphylococcus aureus during infection in epithelial cells. Infect Immun (2014) 0.99
Sigma Factor SigB Is Crucial to Mediate Staphylococcus aureus Adaptation during Chronic Infections. PLoS Pathog (2015) 0.97
Glucose Augments Killing Efficiency of Daptomycin Challenged Staphylococcus aureus Persisters. PLoS One (2016) 0.93
Bacterial Adaptation during Chronic Respiratory Infections. Pathogens (2015) 0.92
SigB is a dominant regulator of virulence in Staphylococcus aureus small-colony variants. PLoS One (2013) 0.90
Staphylococcus aureus dynamically adapts global regulators and virulence factor expression in the course from acute to chronic infection. Curr Genet (2015) 0.90
Clinical Significance and Pathogenesis of Staphylococcal Small Colony Variants in Persistent Infections. Clin Microbiol Rev (2016) 0.89
Characterization of the modular design of the autolysin/adhesin Aaa from Staphylococcus aureus. PLoS One (2012) 0.88
Phenotype switching is a natural consequence of Staphylococcus aureus replication. J Bacteriol (2012) 0.88
Tomatidine inhibits replication of Staphylococcus aureus small-colony variants in cystic fibrosis airway epithelial cells. Antimicrob Agents Chemother (2011) 0.87
Bacteria tracking by in vivo magnetic resonance imaging. BMC Biol (2013) 0.87
Comparative proteome analysis reveals conserved and specific adaptation patterns of Staphylococcus aureus after internalization by different types of human non-professional phagocytic host cells. Front Microbiol (2014) 0.86
Differential responses of osteoblasts and macrophages upon Staphylococcus aureus infection. BMC Microbiol (2014) 0.86
High-resolution transcriptomic analysis of the adaptive response of Staphylococcus aureus during acute and chronic phases of osteomyelitis. MBio (2014) 0.85
Return of the Trojan horse: intracellular phenotype switching and immune evasion by Staphylococcus aureus. EMBO Mol Med (2011) 0.84
The dynamics of T cells during persistent Staphylococcus aureus infection: from antigen-reactivity to in vivo anergy. EMBO Mol Med (2011) 0.84
Effect of low temperature on growth and ultra-structure of Staphylococcus spp. PLoS One (2012) 0.84
Decreased susceptibility of Staphylococcus aureus small-colony variants toward human antimicrobial peptides. J Invest Dermatol (2014) 0.84
Complete Genome Sequence of Staphylococcus aureus 6850, a Highly Cytotoxic and Clinically Virulent Methicillin-Sensitive Strain with Distant Relatedness to Prototype Strains. Genome Announc (2013) 0.83
Phenol-soluble modulin α induces G2/M phase transition delay in eukaryotic HeLa cells. FASEB J (2015) 0.83
Evolution in fast forward: a potential role for mutators in accelerating Staphylococcus aureus pathoadaptation. J Bacteriol (2012) 0.83
Pharmacodynamic evaluation of the activity of antibiotics against hemin- and menadione-dependent small-colony variants of Staphylococcus aureus in models of extracellular (broth) and intracellular (THP-1 monocytes) infections. Antimicrob Agents Chemother (2012) 0.83
Staphylococcus aureus adapts to oxidative stress by producing H2O2-resistant small-colony variants via the SOS response. Infect Immun (2015) 0.82
Evolution of Staphylococcus aureus under vancomycin selective pressure: the role of the small-colony variant phenotype. Antimicrob Agents Chemother (2014) 0.82
Natural mutations in a Staphylococcus aureus virulence regulator attenuate cytotoxicity but permit bacteremia and abscess formation. Proc Natl Acad Sci U S A (2016) 0.81
Response to "In vivo attenuation and genetic evolution of a ST247-SCCmecI MRSA clone after 13 years of pathogenic bronchopulmonary colonization in a patient with cystic fibrosis: implications of the innate immune response". Mucosal Immunol (2015) 0.81
Innate Immune Signaling Activated by MDR Bacteria in the Airway. Physiol Rev (2016) 0.81
RNA-Seq reveals differential gene expression in Staphylococcus aureus with single-nucleotide resolution. PLoS One (2013) 0.80
Identification and treatment of the Staphylococcus aureus reservoir in vivo. J Exp Med (2016) 0.79
The MazEF Toxin-Antitoxin System Alters the β-Lactam Susceptibility of Staphylococcus aureus. PLoS One (2015) 0.79
Antimicrobial activity against intraosteoblastic Staphylococcus aureus. Antimicrob Agents Chemother (2015) 0.79
Thymidine-Dependent Staphylococcus aureus Small-Colony Variants Are Induced by Trimethoprim-Sulfamethoxazole (SXT) and Have Increased Fitness during SXT Challenge. Antimicrob Agents Chemother (2015) 0.79
Staphylococcus aureus sortase A contributes to the Trojan horse mechanism of immune defense evasion with its intrinsic resistance to Cys184 oxidation. Biochemistry (2011) 0.78
The Agr quorum-sensing system regulates fibronectin binding but not hemolysis in the absence of a functional electron transport chain. Infect Immun (2014) 0.78
Rhodomyrtone modulates innate immune responses of THP-1 monocytes to assist in clearing methicillin-resistant Staphylococcus aureus. PLoS One (2014) 0.78
Novel Pathways for Ameliorating the Fitness Cost of Gentamicin Resistant Small Colony Variants. Front Microbiol (2016) 0.77
Omics Approaches for the Study of Adaptive Immunity to Staphylococcus aureus and the Selection of Vaccine Candidates. Proteomes (2016) 0.77
Staphylococcus aureus vs. Osteoblast: Relationship and Consequences in Osteomyelitis. Front Cell Infect Microbiol (2015) 0.77
Knockdown of TNFR1 Suppresses Expression of TLR2 in the Cellular Response to Staphylococcus aureus Infection. Inflammation (2016) 0.77
Biochemical insights into the function of phage G1 gp67 in Staphylococcus aureus. Bacteriophage (2013) 0.76
Catheter colonization and abscess formation due to Staphylococcus epidermidis with normal and small-colony-variant phenotype is mouse strain dependent. PLoS One (2012) 0.76
Intrahost Evolution of Methicillin-Resistant Staphylococcus aureus USA300 Among Individuals With Reoccurring Skin and Soft-Tissue Infections. J Infect Dis (2016) 0.75
Suppression of starvation-induced autophagy by recombinant toxic shock syndrome toxin-1 in epithelial cells. PLoS One (2014) 0.75
Accessory gene regulator (Agr) functionality in Staphylococcus aureus derived from lower respiratory tract infections. PLoS One (2017) 0.75
Effect of common and experimental anti-tuberculosis treatments on Mycobacterium tuberculosis growing as biofilms. PeerJ (2016) 0.75
A Network Biology Approach to Decipher Stress Response in Bacteria Using Escherichia coli As a Model. OMICS (2016) 0.75
Efficacy of vaccination and nisin Z treatments to eliminate intramammary Staphylococcus aureus infection in lactating cows. J Zhejiang Univ Sci B (2017) 0.75
The osteoblast as an inflammatory cell: production of cytokines in response to bacteria and components of bacterial biofilms. BMC Musculoskelet Disord (2016) 0.75
The T Cell Response to Staphylococcus aureus. Pathogens (2016) 0.75
Bacterial Strain Diversity Within Wounds. Adv Wound Care (New Rochelle) (2015) 0.75
Moving towards the immunodiagnosis of staphylococcal intramammary infections. Eur J Clin Microbiol Infect Dis (2014) 0.75
Macrophage adaptation leads to parallel evolution of genetically diverse Escherichia coli small-colony variants with increased fitness in vivo and antibiotic collateral sensitivity. Evol Appl (2016) 0.75
Staphylococcus aureus-dependent septic arthritis in murine knee joints: local immune response and beneficial effects of vaccination. Sci Rep (2016) 0.75
The Small Colony Variant of Listeria monocytogenes Is More Tolerant to Antibiotics and Has Altered Survival in RAW 264.7 Murine Macrophages. Front Microbiol (2016) 0.75
Mitogen-activated protein kinases (MAPKs) regulate IL-6 over-production during concomitant influenza virus and Staphylococcus aureus infection. Sci Rep (2017) 0.75
A long-term epigenetic memory switch controls bacterial virulence bimodality. Elife (2017) 0.75
Reduced Innate Immune Response to a Staphylococcus aureus Small Colony Variant Compared to Its Wild-Type Parent Strain. Front Cell Infect Microbiol (2016) 0.75
Influence of IS256 on genome variability and formation of SCV in Staphylococcus aureus. Antimicrob Agents Chemother (2017) 0.75
Staphylococcal protein A promotes osteoclastogenesis through MAPK signaling during bone infection. J Cell Physiol (2017) 0.75
Intracellular Survival of Staphylococcus aureus in Endothelial Cells: A Matter of Growth or Persistence. Front Microbiol (2017) 0.75
Staphylococcus aureus infections. N Engl J Med (1998) 36.39
Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest (1973) 31.28
Exploring the full spectrum of macrophage activation. Nat Rev Immunol (2008) 26.08
Bacterial persistence as a phenotypic switch. Science (2004) 15.80
Autoinduction and signal transduction in the regulation of staphylococcal virulence. Mol Microbiol (2003) 10.68
Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clin Microbiol Rev (2010) 9.82
Persister cells, dormancy and infectious disease. Nat Rev Microbiol (2006) 8.35
Persister cells. Annu Rev Microbiol (2010) 7.24
Alpha-toxin of Staphylococcus aureus. Microbiol Rev (1991) 6.14
Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections. Nat Rev Microbiol (2006) 5.73
Experimental evolution of bet hedging. Nature (2009) 3.92
Persistent infection with small colony variant strains of Staphylococcus aureus in patients with cystic fibrosis. J Infect Dis (1998) 3.61
Persistent and relapsing infections associated with small-colony variants of Staphylococcus aureus. Clin Infect Dis (1995) 3.49
A site-directed Staphylococcus aureus hemB mutant is a small-colony variant which persists intracellularly. J Bacteriol (1997) 3.25
Evolution of microbial diversity during prolonged starvation. Proc Natl Acad Sci U S A (1999) 3.18
Fibronectin-binding protein acts as Staphylococcus aureus invasin via fibronectin bridging to integrin alpha5beta1. Cell Microbiol (1999) 3.17
Gentamicin-resistant menadione and hemin auxotrophic Staphylococcus aureus persist within cultured endothelial cells. J Infect Dis (1994) 2.91
Microbial awakenings. Nature (2009) 2.90
Recovery of small colony variants of Staphylococcus aureus following gentamicin bead placement for osteomyelitis. Clin Infect Dis (1997) 2.82
Staphylococcus aureus small colony variants in prosthetic joint infection. Clin Infect Dis (2006) 2.53
Staphylococcus aureus as an intracellular pathogen: the role of small colony variants. Trends Microbiol (2009) 2.38
agr function in clinical Staphylococcus aureus isolates. Microbiology (2008) 2.33
Regulation of phenotypic variability by a threshold-based mechanism underlies bacterial persistence. Proc Natl Acad Sci U S A (2010) 2.20
Small-colony variants of Pseudomonas aeruginosa in cystic fibrosis. Clin Infect Dis (1999) 2.18
Increased expression of clumping factor and fibronectin-binding proteins by hemB mutants of Staphylococcus aureus expressing small colony variant phenotypes. Infect Immun (2002) 2.08
Osteoblastic 11beta-hydroxysteroid dehydrogenase type 1 activity increases with age and glucocorticoid exposure. J Bone Miner Res (2002) 1.94
Phenotype microarray profiling of Staphylococcus aureus menD and hemB mutants with the small-colony-variant phenotype. J Bacteriol (2006) 1.81
Staphylococcus aureus subvert autophagy for induction of caspase-independent host cell death. J Biol Chem (2006) 1.73
A global view of Staphylococcus aureus whole genome expression upon internalization in human epithelial cells. BMC Genomics (2007) 1.73
Phenotypic switching of antibiotic resistance circumvents permanent costs in Staphylococcus aureus. Curr Biol (2001) 1.48
Fibronectin-induced agglutination of Staphylococcus aureus correlates with invasiveness. J Lab Clin Med (1984) 1.46
Decreased susceptibility to antibiotic killing of a stable small colony variant of Staphylococcus aureus in fluid phase and on fibronectin-coated surfaces. J Antimicrob Chemother (1997) 1.44
Staphylococcus aureus small colony variants are induced by the endothelial cell intracellular milieu. J Infect Dis (1996) 1.43
Staphylococcus aureus small-colony variants are adapted phenotypes for intracellular persistence. J Infect Dis (2010) 1.43
Management of Staphylococcus aureus bacteremia and endocarditis: progresses and challenges. Curr Opin Infect Dis (2010) 1.42
Staphylococcus aureus small colony variants: a challenge to microbiologists and clinicians. Int J Antimicrob Agents (2008) 1.36
Multiple virulence factors are required for Staphylococcus aureus-induced apoptosis in endothelial cells. Cell Microbiol (2005) 1.35
Thymidine-dependent Staphylococcus aureus small-colony variants are associated with extensive alterations in regulator and virulence gene expression profiles. Infect Immun (2005) 1.35
Identification of differentially expressed small non-protein-coding RNAs in Staphylococcus aureus displaying both the normal and the small-colony variant phenotype. J Mol Med (Berl) (2010) 1.32
High phenotypic diversity in infecting but not in colonizing Staphylococcus aureus populations. Environ Microbiol (2007) 1.17
Bacterial pathogens and the autophagic response. Cell Microbiol (2009) 1.16
Staphylococcus aureus sigma B-dependent emergence of small-colony variants and biofilm production following exposure to Pseudomonas aeruginosa 4-hydroxy-2-heptylquinoline-N-oxide. BMC Microbiol (2010) 1.16
Staphylococcus aureus induces caspase-independent cell death in human peritoneal mesothelial cells. Kidney Int (2006) 1.10
Virulent gentamicin-induced small colony variants of Staphylococcus aureus. J Lab Clin Med (1979) 1.09
Characterization of clinical Enterococcus faecalis small-colony variants. J Clin Microbiol (2009) 1.08
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 6-1993. A 69-year-old woman with a sclerotic lesion of the femur and pulmonary nodules. N Engl J Med (1993) 1.07
Intracellular residency is frequently associated with recurrent Staphylococcus aureus rhinosinusitis. Rhinology (2006) 1.04
The microbiology of chronic osteomyelitis: prevalence of resistance to common empirical anti-microbial regimens. J Infect (2010) 1.01
Reduced adherence and host cell invasion by methicillin-resistant Staphylococcus aureus expressing the surface protein Pls. J Infect Dis (2004) 0.99
A role for sigma factor B in the emergence of Staphylococcus aureus small-colony variants and elevated biofilm production resulting from an exposure to aminoglycosides. Microb Pathog (2009) 0.98
Staphylococcus aureus SigB activity promotes a strong fibronectin-bacterium interaction which may sustain host tissue colonization by small-colony variants isolated from cystic fibrosis patients. Mol Microbiol (2008) 0.96
Staphylococcal strains vary greatly in their ability to induce an inflammatory response in endothelial cells. J Infect Dis (2010) 0.94
Detection of Staphylococcus aureus by 16S rRNA directed in situ hybridisation in a patient with a brain abscess caused by small colony variants. J Neurol Neurosurg Psychiatry (2003) 0.88
Phagolysosomal integrity is generally maintained after Staphylococcus aureus invasion of nonprofessional phagocytes but is modulated by strain 6850. Infect Immun (2010) 0.88
Synthesis and discovery of autophagy inducers for A549 and H460 lung cancer cells, novel 1-(2'-hydroxy-3'-aroxypropyl)-3-aryl-1H-pyrazole-5-carbohydrazide derivatives. Bioorg Med Chem Lett (2008) 0.86
Fourier-transform infrared spectroscopic analysis is a powerful tool for studying the dynamic changes in Staphylococcus aureus small-colony variants. J Clin Microbiol (2006) 0.85
Identification of antimicrobial compounds active against intracellular Staphylococcus aureus. FEMS Immunol Med Microbiol (2005) 0.81
Characterisation of the Escherichia coli strain associated with an outbreak of haemolytic uraemic syndrome in Germany, 2011: a microbiological study. Lancet Infect Dis (2011) 8.25
Pathogenesis of infections due to coagulase-negative staphylococci. Lancet Infect Dis (2002) 5.94
Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections. Nat Rev Microbiol (2006) 5.73
Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock. Nat Med (2007) 5.47
Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein. J Exp Med (2008) 5.23
S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules. J Leukoc Biol (2006) 4.20
Failures in clinical treatment of Staphylococcus aureus Infection with daptomycin are associated with alterations in surface charge, membrane phospholipid asymmetry, and drug binding. Antimicrob Agents Chemother (2007) 3.54
Phagocytosis-independent antimicrobial activity of mast cells by means of extracellular trap formation. Blood (2008) 3.32
A novel mechanism of rapid nuclear neutrophil extracellular trap formation in response to Staphylococcus aureus. J Immunol (2010) 3.20
Crucial role for human Toll-like receptor 4 in the development of contact allergy to nickel. Nat Immunol (2010) 3.15
Staphylococcus aureus panton-valentine leukocidin is a very potent cytotoxic factor for human neutrophils. PLoS Pathog (2010) 3.11
The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer. J Leukoc Biol (2009) 3.01
Zinc sequestration by the neutrophil protein calprotectin enhances Salmonella growth in the inflamed gut. Cell Host Microbe (2012) 2.66
A multicenter trial to compare blood culture with polymerase chain reaction in severe human sepsis. Intensive Care Med (2009) 2.60
Development and evaluation of a quality-controlled ribosomal sequence database for 16S ribosomal DNA-based identification of Staphylococcus species. J Clin Microbiol (2004) 2.59
Impact of a molecular approach to improve the microbiological diagnosis of infective heart valve endocarditis. Circulation (2005) 2.51
Archimedean-like tiling on decagonal quasicrystalline surfaces. Nature (2008) 2.46
At the crossroads of bacterial metabolism and virulence factor synthesis in Staphylococci. Microbiol Mol Biol Rev (2009) 2.41
Staphylococcus aureus as an intracellular pathogen: the role of small colony variants. Trends Microbiol (2009) 2.38
Proinflammatory S100 proteins in arthritis and autoimmune disease. Arthritis Rheum (2004) 2.33
Induction of Staphylococcus epidermidis biofilm formation via proteolytic processing of the accumulation-associated protein by staphylococcal and host proteases. Mol Microbiol (2005) 2.29
Prevalence of genes encoding pyrogenic toxin superantigens and exfoliative toxins among strains of Staphylococcus aureus isolated from blood and nasal specimens. J Clin Microbiol (2003) 2.27
Alarmins: awaiting a clinical response. J Clin Invest (2012) 2.19
Mechanisms of disease: a 'DAMP' view of inflammatory arthritis. Nat Clin Pract Rheumatol (2007) 2.18
Loss of S100A9 (MRP14) results in reduced interleukin-8-induced CD11b surface expression, a polarized microfilament system, and diminished responsiveness to chemoattractants in vitro. Mol Cell Biol (2003) 2.17
The epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) in Germany. Dtsch Arztebl Int (2011) 2.11
Increased expression of clumping factor and fibronectin-binding proteins by hemB mutants of Staphylococcus aureus expressing small colony variant phenotypes. Infect Immun (2002) 2.08
Methotrexate withdrawal at 6 vs 12 months in juvenile idiopathic arthritis in remission: a randomized clinical trial. JAMA (2010) 2.02
S100A9/S100A8: Myeloid representatives of the S100 protein family as prominent players in innate immunity. Microsc Res Tech (2003) 1.99
Access to biologic therapies in Canada for children with juvenile idiopathic arthritis. J Rheumatol (2012) 1.97
Influenza A virus inhibits type I IFN signaling via NF-kappaB-dependent induction of SOCS-3 expression. PLoS Pathog (2008) 1.94
Staphylococcus aureus extracellular adherence protein serves as anti-inflammatory factor by inhibiting the recruitment of host leukocytes. Nat Med (2002) 1.92
Phagocyte-specific calcium-binding S100 proteins as clinical laboratory markers of inflammation. Clin Chim Acta (2004) 1.87
Myeloid-related proteins 8 and 14 induce a specific inflammatory response in human microvascular endothelial cells. Blood (2004) 1.85
The small colony variant (SCV) concept -- the role of staphylococcal SCVs in persistent infections. Injury (2006) 1.85
Truncation of fibronectin-binding proteins in Staphylococcus aureus strain Newman leads to deficient adherence and host cell invasion due to loss of the cell wall anchor function. Infect Immun (2004) 1.83
Phenotype microarray profiling of Staphylococcus aureus menD and hemB mutants with the small-colony-variant phenotype. J Bacteriol (2006) 1.81
In vitro susceptibility of Staphylococcus aureus to thrombin-induced platelet microbicidal protein-1 (tPMP-1) is influenced by cell membrane phospholipid composition and asymmetry. Microbiology (2007) 1.80
Infections associated with medical devices: pathogenesis, management and prophylaxis. Drugs (2005) 1.78
Immunological mechanisms underlying the genetic predisposition to severe Staphylococcus aureus infection in the mouse model. Am J Pathol (2008) 1.77
Thymidine-dependent small-colony variants of Staphylococcus aureus exhibit gross morphological and ultrastructural changes consistent with impaired cell separation. J Clin Microbiol (2003) 1.71
MRP8 and MRP14 control microtubule reorganization during transendothelial migration of phagocytes. Blood (2004) 1.71
The Toll-like receptor 4 ligands Mrp8 and Mrp14 are crucial in the development of autoreactive CD8+ T cells. Nat Med (2010) 1.70
Drug-resistant human Staphylococcus aureus in sanctuary apes pose a threat to endangered wild ape populations. Am J Primatol (2012) 1.69
Population dynamics of persistent Staphylococcus aureus isolated from the airways of cystic fibrosis patients during a 6-year prospective study. J Clin Microbiol (2003) 1.69
Physiology and antibiotic susceptibility of Staphylococcus aureus small colony variants. Microb Drug Resist (2002) 1.69
Physiological characterization of a heme-deficient mutant of Staphylococcus aureus by a proteomic approach. J Bacteriol (2003) 1.69
TNF induces distinct gene expression programs in microvascular and macrovascular human endothelial cells. J Leukoc Biol (2006) 1.67
New insights into meticillin-resistant Staphylococcus aureus (MRSA) pathogenesis, treatment and resistance. Int J Antimicrob Agents (2011) 1.66
Identification of human S100A9 as a novel target for treatment of autoimmune disease via binding to quinoline-3-carboxamides. PLoS Biol (2009) 1.65
Expression of myeloid-related protein-8 and -14 in patients with acute Kawasaki disease. J Am Coll Cardiol (2006) 1.65
Effects of antibiotics on Shiga toxin 2 production and bacteriophage induction by epidemic Escherichia coli O104:H4 strain. Antimicrob Agents Chemother (2012) 1.62
Carotenoid-related alteration of cell membrane fluidity impacts Staphylococcus aureus susceptibility to host defense peptides. Antimicrob Agents Chemother (2010) 1.62
Immune-responsive gene 1 protein links metabolism to immunity by catalyzing itaconic acid production. Proc Natl Acad Sci U S A (2013) 1.62
Prevalence of genes encoding for members of the staphylococcal leukotoxin family among clinical isolates of Staphylococcus aureus. Diagn Microbiol Infect Dis (2004) 1.61
Glucocorticoids induce differentiation of a specifically activated, anti-inflammatory subtype of human monocytes. Blood (2006) 1.58
Transcriptional profiling of IKK2/NF-kappa B- and p38 MAP kinase-dependent gene expression in TNF-alpha-stimulated primary human endothelial cells. Blood (2004) 1.56
Sequencing and staphylococci identification. Emerg Infect Dis (2006) 1.54
Synovial histopathology of psoriatic arthritis, both oligo- and polyarticular, resembles spondyloarthropathy more than it does rheumatoid arthritis. Arthritis Res Ther (2005) 1.52
Pneumococcal association to platelets is mediated by soluble fibrin and supported by thrombospondin-1. Thromb Haemost (2009) 1.51
Redox sensing by a Rex-family repressor is involved in the regulation of anaerobic gene expression in Staphylococcus aureus. Mol Microbiol (2010) 1.49
Role of macrophages in host resistance to group A streptococci. Infect Immun (2004) 1.49
Synovial lining macrophages mediate osteophyte formation during experimental osteoarthritis. Osteoarthritis Cartilage (2004) 1.47
Calcium-dependent tetramer formation of S100A8 and S100A9 is essential for biological activity. J Mol Biol (2006) 1.46
Duration of fecal shedding of Shiga toxin-producing Escherichia coli O104:H4 in patients infected during the 2011 outbreak in Germany: a multicenter study. Clin Infect Dis (2013) 1.46
Staphylococcal extracellular adherence protein induces platelet activation by stimulation of thiol isomerases. Arterioscler Thromb Vasc Biol (2012) 1.45
Staphylococcus epidermidis polysaccharide intercellular adhesin production significantly increases during tricarboxylic acid cycle stress. J Bacteriol (2005) 1.44
Cerebral arterial stenoses and stroke: novel features of Aicardi-Goutières syndrome caused by the Arg164X mutation in SAMHD1 are associated with altered cytokine expression. Hum Mutat (2010) 1.43
The multifunctional Staphylococcus aureus autolysin aaa mediates adherence to immobilized fibrinogen and fibronectin. Infect Immun (2005) 1.43
Staphylococcus aureus small-colony variants are adapted phenotypes for intracellular persistence. J Infect Dis (2010) 1.43
Alarmins S100A8 and S100A9 elicit a catabolic effect in human osteoarthritic chondrocytes that is dependent on Toll-like receptor 4. Arthritis Rheum (2012) 1.42
Staphylococcus lugdunensis pacemaker-related infection. Emerg Infect Dis (2005) 1.42
IκBζ is a transcriptional key regulator of CCL2/MCP-1. J Immunol (2013) 1.41
Livestock-associated methicillin-resistant Staphylococcus aureus (MRSA) as causes of human infection and colonization in Germany. PLoS One (2013) 1.41